Quarterly report pursuant to Section 13 or 15(d)

3. Significant Strategic Drug Development Collaborations (Details Narrative)

v3.8.0.1
3. Significant Strategic Drug Development Collaborations (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Significant Strategic Collaborations    
Income from collaborative agreements $ 0 $ 0